ProMIS Neurosciences (PMN) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-1.84 and quarterly revenue of N/A.
In the most recent quarter (Q1), ProMIS Neurosciences reported EPS of $-1.26, beating estimates of $-1.58 by 0.20%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
ProMIS Neurosciences has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, ProMIS Neurosciences has averaged an EPS surprise of 0.29% and a revenue surprise of 0.00%.
Analyze the earnings history of ProMIS Neurosciences using advanced sorting and filters.
The chart below shows ProMIS Neurosciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows ProMIS Neurosciences's reported revenue compared to analyst estimates over recent quarters.
ProMIS Neurosciences (PMN) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 12, 2026 for Q1.
The Actual EPS was $-1.26, which beat the estimate of $-1.58.
The Actual Revenue was $0, which hit the estimate of $0.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-12 | $-1.26 | $-1.58 | 20.3 % |
| Q4 | 2026-03-25 | $-3.11 | $-5.71 | 45.5 % |
| Q3 | 2025-11-12 | $-6.00 | $-7.50 | 20.0 % |
| Q2 | 2025-08-13 | $-7.25 | $-5.50 | -31.8 % |